Literature DB >> 4145285

Determination of sulphapyridine and its metabolites in biological materials after administration of salicylazosulphapyridine.

K A Hansson, M Sandberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4145285

Source DB:  PubMed          Journal:  Acta Pharm Suec        ISSN: 0001-6675


× No keyword cloud information.
  23 in total

1.  Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.

Authors:  R E Pounder; E R Craven; J S Henthorn; J M Bannatyne
Journal:  Gut       Date:  1975-03       Impact factor: 23.059

2.  Inhibition of cell mediated cytotoxicity by sulphasalazine: effect of in vivo treatment with 5-aminosalicylic acid and sulphasalazine on in vitro natural killer cell activity.

Authors:  M N Aparicio-Pagés; H W Verspaget; J C Hafkenscheid; G E Crama-Bohbouth; A S Peña; I T Weterman; H W Lamers
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.

Authors:  G O Cowan; K M Das; M A Eastwood
Journal:  Br Med J       Date:  1977-10-22

5.  The effect of the acetylator phenotype on the metabolism of sulphasalazine in man.

Authors:  A K Azad Khan; M Nurazzaman; S C Truelove
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

6.  Azo reduction of sulphasalazine in healthy volunteers.

Authors:  J B Houston; J Day; J Walker
Journal:  Br J Clin Pharmacol       Date:  1982-09       Impact factor: 4.335

7.  Sulphasalazine retention enemas in ulcerative colitis.

Authors:  H A Serebro; S Kay
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-11

8.  The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man.

Authors:  A K Azadkhan; S C Truelove; J K Aronson
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

9.  The metabolism of salicylazosulphapyridine in ulcerative colitis: II The relationship between metabolites and the progress of the disease studied in outpatients.

Authors: 
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

10.  Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.

Authors:  H Allgayer; W Kruis; J Eisenburg; G Paumgartner
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.